Related Experiment Video
Updated: Jan 24, 2026

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Role of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review
Ahmed Ismaeel1, Jeong-Su Kim2, Jeffrey S Kirk3
1Department of Nutrition, Food & Exercise Sciences, Florida State University, Tallahassee, FL 32304, USA. ai18@my.fsu.edu.
Abstract:
Transforming growth factor-beta (TGF-β) isoforms are cytokines involved in a variety of cellular processes, including myofiber repair and regulation of connective tissue formation. Activation of the TGF-β pathway contributes to pathologic fibrosis in most organs. Here, we have focused on examining the evidence demonstrating the involvement of TGF-β in the fibrosis of skeletal muscle particularly. The TGF-β pathway plays a role in different skeletal muscle myopathies, and TGF-β signaling is highly induced in these diseases. In this review, we discuss different molecular mechanisms of TGF-β-mediated skeletal muscle fibrosis and highlight different TGF-β-targeted treatments that target these relevant pathways.
Insights
Transforming growth factor-beta (TGF-β) drives skeletal muscle fibrosis in various myopathies. This review explores TGF-β
Area of Science:
- Molecular biology
- Cellular processes
- Tissue repair
Background:
- Transforming growth factor-beta (TGF-β) isoforms are key cytokines regulating cellular functions.
- TGF-β pathway activation is a significant contributor to pathological fibrosis across multiple organs.
- Skeletal muscle fibrosis is implicated in various myopathies, with elevated TGF-β signaling.
Purpose of the Study:
- To review the molecular mechanisms underlying TGF-β-mediated skeletal muscle fibrosis.
- To highlight therapeutic strategies targeting the TGF-β pathway for skeletal muscle fibrosis.
Main Methods:
- Literature review of studies on TGF-β and skeletal muscle fibrosis.
- Analysis of molecular pathways involved in TGF-β-induced fibrosis.
- Examination of current and potential TGF-β-targeted treatments.
Main Results:
- TGF-β signaling is a central mediator in the development of skeletal muscle fibrosis.
- Specific molecular mechanisms link TGF-β activation to fibrotic changes in muscle tissue.
- Various therapeutic approaches targeting TGF-β are under investigation.
Conclusions:
- The TGF-β pathway is a critical factor in skeletal muscle fibrosis.
- Targeting TGF-β offers a promising therapeutic avenue for treating skeletal muscle myopathies and fibrosis.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Classification of Skeletal Muscle Fibers
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Relaxation of Skeletal Muscles
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
Overview of Skeletal Muscle
Skeletal Muscle Anatomy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

